REQUEST A DEMO
Total
USD $0.00
Search more companies

Parra Gomez Claudia Liliana (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Parra Gomez Claudia Liliana Profile Updated: April 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Parra Gomez Claudia Liliana is an enterprise located in Colombia, with the main office in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on July 27, 2001. It currently has a total number of 1 (2024) employees. There was a net sales revenue increase of 124.23% reported in Parra Gomez Claudia Liliana’s latest financial highlights for 2025. Its total assets grew by 98.05% over the same period. In, 2025, the company’s net profit margin increased by 0.9%.

Headquarters
Cra. 34 # 44-54
Bucaramanga; Santander;

Contact Details: Purchase the Parra Gomez Claudia Liliana report to view the information.

Website: http://www.saludmedicalsa.com

Basic Information
Total Employees:
Purchase the Parra Gomez Claudia Liliana report to view the information.
Financial Auditors:
Purchase the Parra Gomez Claudia Liliana report to view the information.
Incorporation Date:
July 27, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Parra Gomez Claudia Liliana report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
124.23%
Total Operating Revenue
124.23%
Net Profit/Loss for the Period
346.6%
Total Assets
98.05%
Total Equity
46.51%
Net Profit Margin
0.9%
Return on Equity (ROE)
2.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?